SpyGlass Pharma, Inc. SEC EDGAR Filings (CIK 0001778922)

SEC EDGAR filings, ownership reports, and insider transactions for SpyGlass Pharma, Inc..

Symbol
SGP
Business address
27081 Aliso Creek Road, Suite 125, Aliso Viejo, CA, 92656
State of incorporation
DE
Fiscal year end
31 December
Former names
SpyGlassPharma, Inc. (to 05 Jun 2025), SpyGlass Ophthalmics, Inc. (to 05 Jan 2021)
Get insider transactions for this issuer
SpyGlass Pharma, Inc. has filed 52 SEC EDGAR filings since 05 Jun 2019

Latest Filings

Recent SEC filings for SpyGlass Pharma, Inc. including 4, 8-K, S-8 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 09 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 4 09 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 09 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 09 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 09 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 09 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 09 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 09 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 09 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 09 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 09 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 09 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 09 Feb 2026 05 Feb 2026
4 Open 4 document View SEC filing for 4 09 Feb 2026 05 Feb 2026
8-K Open 8-K document View SEC filing for 8-K 8-K 09 Feb 2026 05 Feb 2026 001-43105
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 06 Feb 2026 333-293280
424B4 Open 424B4 document View SEC filing for 424B4 424B4 06 Feb 2026 333-292779
3 Open 3 document View SEC filing for 3 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 05 Feb 2026 05 Feb 2026
3 Open 3 document View SEC filing for 3 05 Feb 2026 05 Feb 2026
CERT Open CERT document View SEC filing for CERT 05 Feb 2026 001-43105
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 05 Feb 2026 001-43105
EFFECT Open EFFECT document View SEC filing for EFFECT 30 Jan 2026 333-292779
S-1/A Open S-1/A document | Open XBRL data View SEC filing for S-1/A S-1 29 Jan 2026 333-292779
S-1 Open S-1 document | Open XBRL data View SEC filing for S-1 S-1 16 Jan 2026 333-292779
DRS/A Open DRS/A document View SEC filing for DRS/A 10 Dec 2025 377-08508
DRS Open DRS document View SEC filing for DRS 26 Sep 2025 377-08508
D Open D document View SEC filing for D 05 Jun 2025 021-548147
D Open D document View SEC filing for D 11 Jul 2023 021-486492
D Open D document View SEC filing for D 05 Jan 2021 021-385257
D Open D document View SEC filing for D 05 Jun 2019 021-341181

About this filer

SpyGlass Pharma, Inc. files with the SEC under CIK 0001778922. This page aggregates EDGAR filings and related ownership activity.

Industry: Surgical & Medical Instruments & Apparatus.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages